Internal Medicine, Hematology & Oncology · Sacramento, CA
NPI
1508944216
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2025 Morse Ave
Sacramento, CA, 95825
Phone (916) 973-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
3,340 services
Medicare patients, 2024
11
Average age 67
Drug cost, 2024
$4.6M
1,595 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Lai Hui prescribed most often to Medicare patients was Anastrozole, with 320 prescriptions and refills. In total Lai Hui wrote 1,595 Medicare prescriptions that cost $4.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 320 | 949 | 99 | $8,765 |
| Letrozole Generic | 137 | 408 | 54 | $2,801 |
| Tamoxifen Citrate Generic | 108 | 356 | 39 | $2,940 |
| Dexamethasone Generic | 89 | 99 | 35 | $1,316 |
| Ondansetron Hcl Generic | 82 | 82 | 41 | $667 |
| Ibrance Palbociclib | 76 | 76 | Under 11 | $1.2M |
| Zejula Niraparib Tosylate | 39 | 45 | Under 11 | $656K |
| Exemestane Generic | 37 | 104 | Under 11 | $2,817 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 35 | 35 | 14 | $941 |
| Nivestym Filgrastim-Aafi | 33 | 33 | Under 11 | $20K |
| Lynparza Olaparib | 32 | 32 | Under 11 | $486K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 29 | 29 | 17 | $378 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 28 | 28 | Under 11 | $604 |
| Famotidine Generic | 27 | 28 | 23 | $198 |
| Kisqali Ribociclib Succinate | 27 | 27 | Under 11 | $399K |
Brand drugs: 377 claims; generic drugs: 1,218 claims; opioid claims: 82.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Lai Hui were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.